Accretion Pharmaceuticals launched its IPO on May 14, aiming to raise Rs 29.75 crore through a fresh issue of shares, with the IPO closing on May 16. The Gujarat-based company, which manufactures a range of healthcare products, plans to use the funds for capital expenditure, debt repayment, and working capital.
Defying gravity: This smallcap stock surges 22% in just two sessions after BNP Paribas buys stake
Unified Data Tech surged 16% to a 52-week high of ₹387 on strong volumes following a block deal where BNP Paribas acquired over 1 lakh